Trial Profile
Phase IV study of national extension of HeberPAG use in patients with basal cell carcinoma to assess effectiveness and safety at the population level
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Interferon-alpha-2b/interferon-gamma (Primary)
- Indications Basal cell cancer; Carcinoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms InCarbacel-IV
- 18 Dec 2013 New trial record